Nuvo Pharmaceuticals Inc. carries a market capitalization of 11.15M, placing it among publicly traded companies globally.
| Market Cap | 11.15M |
| Enterprise Value | N/A |
Nuvo Pharmaceuticals Inc.'s stock has declined approximately -16.99153% over the past 52 weeks. The 50-day moving average sits at 0.97, while the 200-day moving average is 0.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.99153% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 0.66 |
| Average Volume (20 Days) | N/A |
Nuvo Pharmaceuticals Inc.'s most recent stock split took place on March 7, 2016 with a 500:677 split ratio.
| Last Split Date | 3/7/2016 |
| Split Ratio | 500:677 |